4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
PMV Pharmaceuticals, Inc. (PMVP) operates in the Biotechnology industry and is headquartered in Princeton, United States with about 54 employees. Its market capitalization is roughly $71 million. In the fiscal year ended 2025-12-31, PMVP reported $0M in revenue and ($78M) in net income.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($86M) | ($85M) | ($80M) | ($77M) |
| Net Income | ($78M) | ($59M) | ($69M) | ($73M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($19M) | ($19M) | ($22M) | ($23M) | ($22M) |
| Net Income | ($18M) | ($18M) | ($21M) | ($21M) | ($17M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $117M | $191M | $252M | $270M | — |
| Total Liabilities | $12M | $15M | $26M | $24M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PMVP viewer.
About TickerBase · Data methodology & sources